X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA AUROBINDO PHARMA AJANTA PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 20.0 17.7 112.5% View Chart
P/BV x 8.6 5.8 149.7% View Chart
Dividend Yield % 0.7 0.4 193.4%  

Financials

 AJANTA PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
AUROBINDO PHARMA
Mar-16
AJANTA PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7201,541 111.6%   
Low Rs1,103582 189.5%   
Sales per share (Unadj.) Rs194.6237.5 82.0%  
Earnings per share (Unadj.) Rs45.233.9 133.5%  
Cash flow per share (Unadj.) Rs50.340.6 123.9%  
Dividends per share (Unadj.) Rs8.002.50 320.0%  
Dividend yield (eoy) %0.60.2 240.6%  
Book value per share (Unadj.) Rs132.0120.6 109.5%  
Shares outstanding (eoy) m88.77585.17 15.2%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x7.34.5 162.3%   
Avg P/E ratio x31.231.3 99.6%  
P/CF ratio (eoy) x28.126.2 107.3%  
Price / Book Value ratio x10.78.8 121.5%  
Dividend payout %17.77.4 239.7%   
Avg Mkt Cap Rs m125,299621,041 20.2%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m2,57015,508 16.6%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m17,275138,961 12.4%  
Other income Rs m1661,663 10.0%   
Total revenues Rs m17,442140,624 12.4%   
Gross profit Rs m5,80732,056 18.1%  
Depreciation Rs m4513,926 11.5%   
Interest Rs m492,568 1.9%   
Profit before tax Rs m5,47427,225 20.1%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4607,444 19.6%   
Profit after tax Rs m4,01419,820 20.3%  
Gross profit margin %33.623.1 145.7%  
Effective tax rate %26.727.3 97.5%   
Net profit margin %23.214.3 162.9%  
BALANCE SHEET DATA
Current assets Rs m7,639100,015 7.6%   
Current liabilities Rs m2,71574,759 3.6%   
Net working cap to sales %28.518.2 156.8%  
Current ratio x2.81.3 210.3%  
Inventory Days Days43107 40.3%  
Debtors Days Days79110 71.8%  
Net fixed assets Rs m6,91452,350 13.2%   
Share capital Rs m177585 30.2%   
"Free" reserves Rs m11,44267,707 16.9%   
Net worth Rs m11,72170,567 16.6%   
Long term debt Rs m1498,472 1.8%   
Total assets Rs m14,814156,994 9.4%  
Interest coverage x112.911.6 973.4%   
Debt to equity ratio x00.1 10.6%  
Sales to assets ratio x1.20.9 131.7%   
Return on assets %27.414.3 192.3%  
Return on equity %34.228.1 121.9%  
Return on capital %46.537.7 123.3%  
Exports to sales %55.151.0 108.0%   
Imports to sales %6.018.8 31.9%   
Exports (fob) Rs m9,52770,927 13.4%   
Imports (cif) Rs m1,03826,193 4.0%   
Fx inflow Rs m10,42271,015 14.7%   
Fx outflow Rs m1,67828,799 5.8%   
Net fx Rs m8,74442,216 20.7%   
CASH FLOW
From Operations Rs m3,26417,596 18.5%  
From Investments Rs m-2,093-13,801 15.2%  
From Financial Activity Rs m-1,186-198 597.9%  
Net Cashflow Rs m-153,597 -0.4%  

Share Holding

Indian Promoters % 73.8 54.1 136.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 8.0 19.5%  
FIIs % 7.6 27.7 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 10.2 166.7%  
Shareholders   20,968 69,601 30.1%  
Pledged promoter(s) holding % 4.4 8.6 51.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUVEN LIFE  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  MERCK LTD  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 22, 2017 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS